3 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp00814 | AAD (or Aa-Pri1) | MDSNKDERAYAQWVIIILHNVGSSPFKIANLGLSWGKLYADGNKDKEVYPSDYNGKTVGPDEKIQINSCGRENASSGTEGSFDIVDPNDGNKTIRHFYWECPWGSKRNTWTPSGSNTKWMVEWSGQNLDSGALGTITVDVLRKGN | Purified from chestnut mushroom | Apoptosis inducing | MTT/MTS assay | HepG-2 | Liver cancer | At 2.5 µM concentration,decrease in cell vibility: 35% |
| dbacp00815 | AAD (or Aa-Pri1) | MDSNKDERAYAQWVIIILHNVGSSPFKIANLGLSWGKLYADGNKDKEVYPSDYNGKTVGPDEKIQINSCGRENASSGTEGSFDIVDPNDGNKTIRHFYWECPWGSKRNTWTPSGSNTKWMVEWSGQNLDSGALGTITVDVLRKGN | Purified from chestnut mushroom | Apoptosis inducing | MTT/MTS assay | HeLa | Cervical cancer | At 2.5 µM concentration,decrease in cell vibility: 70% |
| dbacp00816 | AAD (or Aa-Pri1) | MDSNKDERAYAQWVIIILHNVGSSPFKIANLGLSWGKLYADGNKDKEVYPSDYNGKTVGPDEKIQINSCGRENASSGTEGSFDIVDPNDGNKTIRHFYWECPWGSKRNTWTPSGSNTKWMVEWSGQNLDSGALGTITVDVLRKGN | Purified from chestnut mushroom | Apoptosis inducing | MTT/MTS assay | SH-SY5Y | Brain tumor | At 2.5 µM concentration,decrease in cell vibility: 70% |